Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Percutaneous Retrieval Dislodged Port Catheter
Author(s): Dharmaraj Karthikesan , Mohd Ridzuan Mohd Said , Chin Yung Chea , et al Added: 4 months ago

Vascular Disease and Surgery

Intervention
Drug-eluting Balloons: Experience from Central India
Author(s): Ajinkya Mahorkar , Virag Mahorkar , Uday Mahorkar , et al Added: 1 month ago

Prevention & Chronic Conditions

Intervention
The QUADRIC Study
Author(s): Wei Juan Lim , David Yong Tat Wei , Yuen Han Lim , et al Added: 1 month ago

Prevention & Chronic Conditions

Intervention
Two Holes in One: A Rare Case of Congenital Mitral Valve Anomaly
Author(s): Ma Liza R Quetulio , Giselle Ann E Llabado , Anne Marie Kathryn I Pineda , et al Added: 1 year ago

Imaging & Diagnostics

Inherited and Congenital Cardiac Conditions
Balloon-expandable versus Self-expanding Valves
Author(s): Jie Jun Wong , Eugene Gan , Fei Gao , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
Safety and Efficacy of Percutaneous PVI: The Singapore Experience
Author(s): Fang Yi Lim , Jie Sheng Foo , Jonathan Jiunn Liang Yap , et al Added: 1 year ago

Inherited and Congenital Cardiac Conditions

Intervention
Percutaneous Management of Ventricular Septal Rupture
Author(s): Kamalesh Anbalakan , Jonathan Jiunn Liang Yap , Jie Sheng Foo , et al Added: 1 year ago

MI/ACS

Intervention
TCT 24: The MATTERHORN Trial
Author(s): Stephan Baldus Added: 6 months ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more

Heart Failure

Intervention
TCT 24: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty
Author(s): Ulf Teichgräber Added: 6 months ago
TCT Conference 2024 - Safety and efficacy outcomes of the trial shows that percutaneous transluminal angioplasty (PTA) with the sirolimus drug coated balloon (DCB) in patients with femoropopliteal artery disease was/was not noninferior to PTA with the paclitaxel DCB.Prof Ulf Teichgräber joins us onsite at TCT Conference to discuss the findings from the sirolimus- vs. paclitaxel-coated balloon… View more

Vascular Disease and Surgery

Intervention
TCT 24: The ECLIPSE Trial
Author(s): Ajay J Kirtane Added: 6 months ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott… View more

Intervention